VICARIO, TOMMASA
 Distribuzione geografica
Continente #
EU - Europa 113
NA - Nord America 83
AF - Africa 2
AS - Asia 1
Totale 199
Nazione #
IT - Italia 103
US - Stati Uniti d'America 82
FR - Francia 9
ZA - Sudafrica 2
CA - Canada 1
DE - Germania 1
TR - Turchia 1
Totale 199
Città #
Rome 79
Milan 20
Fairfield 11
Ashburn 10
Santa Cruz 10
Buffalo 7
Woodbridge 5
Cambridge 4
Dallas 3
Houston 3
Seattle 3
Las Vegas 2
Muizenberg 2
Wilmington 2
Ann Arbor 1
Camerano 1
Chicago 1
Kosekoy 1
Lake Forest 1
Los Angeles 1
Miami 1
Ottawa 1
Paris 1
Phoenix 1
San Cesareo 1
San Francisco 1
Sezze 1
Totale 174
Nome #
Relationship between low Ankle-Brachial Index and rapid renal function decline in patients with atrial fibrillation: a prospective multicentre cohort study, file e383531e-a71f-15e8-e053-a505fe0a3de9 91
Fibrosis-4 (FIB-4) index and mortality in COVID-19 patients admitted to the emergency department, file e383532f-33b8-15e8-e053-a505fe0a3de9 21
Relationship between low Ankle-Brachial Index and rapid renal function decline in patients with atrial fibrillation: a prospective multicentre cohort study, file e383531e-9061-15e8-e053-a505fe0a3de9 16
Cancer-specific ischemic complications in elderly Patients with atrial fibrillation. data from the prospective ATHERO-AF study, file e3835327-62e1-15e8-e053-a505fe0a3de9 11
Carotid plaque detection improves the predictve value of CHA2DS2-VASc score in patients with non-valvular atrial fibrilation. the ARAPACIS study, file e3835323-5bb8-15e8-e053-a505fe0a3de9 8
Digoxin treatment is associated with increased total and cardiovascular mortality in anticoagulated patients with atrial fibrillation, file e3835327-912a-15e8-e053-a505fe0a3de9 7
Inadequate anticoagulation by vitamin K antagonists is associated with major adverse cardiovascular events in patients with atrial fibrillation, file e383531e-8dab-15e8-e053-a505fe0a3de9 6
Reply to. "inadequate anticoagulation by vitamin K antagonists and major adverse cardiovascular events other than stroke", file e383531e-c4d0-15e8-e053-a505fe0a3de9 6
Features of severe COVID-19. a systematic review and meta-analysis, file e3835327-d6d6-15e8-e053-a505fe0a3de9 6
Relationship between Mediterranean diet and time in therapeutic range in atrial fibrillation patients taking Vitamin K antagonists, file e3835315-497d-15e8-e053-a505fe0a3de9 5
Serum NOX2 and urinary isoprostanes predict vascular events in patients with atrial fibrillation, file e3835311-d145-15e8-e053-a505fe0a3de9 4
Does mediterranean diet reduce cardiovascular events and oxidative stress in atrial fibrillation, file e383531b-d98e-15e8-e053-a505fe0a3de9 4
Reply to. "monitoring antivitamin K anticoagulants in antiphospholipid syndrome. a challenge in quality", file e3835328-2a65-15e8-e053-a505fe0a3de9 4
Vitamin E serum levels and bleeding risk in patients receiving oral anticoagulant therapy. A retrospective cohort study, file e3835312-32e3-15e8-e053-a505fe0a3de9 3
Relationship of PCSK9 and urinary thromboxane excretion to cardiovascular events in patients with atrial fibrillation, file e383531d-789e-15e8-e053-a505fe0a3de9 3
Atrial fibrillation pattern, left atrial diameter and risk of cardiovascular events and mortality. a prospective multicenter cohort study, file e3835329-1b9c-15e8-e053-a505fe0a3de9 3
Cancer and atrial fibrillation. epidemiology, mechanisms, and anticoagulation treatment, file e383532c-6363-15e8-e053-a505fe0a3de9 3
Urinary 11-dehydro-thromboxane B2 is associated with cardiovascular events and mortality in atrial fibrillation patients, file e3835317-038f-15e8-e053-a505fe0a3de9 2
Incidence of Myocardial Infarction and Vascular Death in Elderly Patients With Atrial Fibrillation Taking Anticoagulants Relation to Atherosclerotic Risk Factors, file e3835312-60ba-15e8-e053-a505fe0a3de9 1
Extra virgin olive oil blunt post-prandial oxidative stress via NOX2 down-regulation., file e3835312-6843-15e8-e053-a505fe0a3de9 1
Response to "Digoxin or digoxin prescribed patient? Randomized trials are essential to discriminate the principal risk factor for the association of digoxin and increased mortality"., file e3835312-6881-15e8-e053-a505fe0a3de9 1
Antiphospholipid syndrome and anticoagulation quality: A clinical challenge, file e3835314-4cfc-15e8-e053-a505fe0a3de9 1
Anti Xa oral anticoagulants inhibit in vivo platelet activation by modulating glycoprotein VI shedding, file e3835316-3e81-15e8-e053-a505fe0a3de9 1
Totale 208
Categoria #
all - tutte 383
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 383


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20195 0 0 0 0 0 0 0 0 0 0 1 4
2019/202026 1 1 2 1 2 3 2 3 3 5 1 2
2020/202179 4 2 4 17 0 1 1 1 11 28 10 0
2021/202226 1 4 1 0 2 0 1 1 0 2 9 5
2022/202327 1 2 10 2 2 4 1 4 0 0 1 0
2023/202414 0 1 1 1 2 4 1 2 2 0 0 0
Totale 208